Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools.


Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
04 2021
Historique:
received: 02 07 2020
revised: 26 11 2020
entrez: 26 4 2021
pubmed: 27 4 2021
medline: 15 12 2021
Statut: epublish

Résumé

Over the past decades, considerable attention has been dedicated to the exploitation of diverse immune cells as therapeutic and/or diagnostic cell-based microrobots for hard-to-treat disorders. To date, a plethora of therapeutics based on alive immune cells, surface-engineered immune cells, immunocytes' cell membranes, leukocyte-derived extracellular vesicles or exosomes, and artificial immune cells have been investigated and a few have been introduced into the market. These systems take advantage of the unique characteristics and functions of immune cells, including their presence in circulating blood and various tissues, complex crosstalk properties, high affinity to different self and foreign markers, unique potential of their on-demand navigation and activity, production of a variety of chemokines/cytokines, as well as being cytotoxic in particular conditions. Here, the latest progress in the development of engineered therapeutics and diagnostics inspired by immune cells to ameliorate cancer, inflammatory conditions, autoimmune diseases, neurodegenerative disorders, cardiovascular complications, and infectious diseases is reviewed, and finally, the perspective for their clinical application is delineated.

Identifiants

pubmed: 33898169
doi: 10.1002/advs.202002499
pii: ADVS2326
pmc: PMC8061401
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2002499

Informations de copyright

© 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Nanotechnology. 2018 Apr 3;29(13):134004
pubmed: 29334363
Sci Rep. 2019 Dec 12;9(1):18949
pubmed: 31831802
Nat Rev Drug Discov. 2013 May;12(5):347-57
pubmed: 23584393
Sci Rep. 2016 Jun 27;6:28717
pubmed: 27346486
Chem Soc Rev. 2012 Jul 7;41(13):4755-67
pubmed: 22648524
Biomaterials. 2017 Feb;117:44-53
pubmed: 27936416
Adv Drug Deliv Rev. 2015 Aug 30;91:125-40
pubmed: 25543006
Acta Pharm Sin B. 2019 May;9(3):575-589
pubmed: 31193785
Mol Ther. 2011 Feb;19(2):395-9
pubmed: 21102562
Theranostics. 2017 Jul 7;7(10):2732-2745
pubmed: 28819459
Small. 2015 Apr;11(13):1519-25
pubmed: 25641795
Adv Mater. 2018 Jul 10;:e1802378
pubmed: 29989211
J Control Release. 2018 Nov 10;289:56-69
pubmed: 30261205
ACS Nano. 2018 Dec 26;12(12):12096-12108
pubmed: 30444351
J Biomed Opt. 2016 Jan;21(1):18004
pubmed: 26811077
Mol Ther. 2019 Jun 5;27(6):1114-1125
pubmed: 30962163
Nano Lett. 2019 Oct 9;19(10):6945-6954
pubmed: 31478664
Adv Healthc Mater. 2015 Dec 30;4(18):2832-41
pubmed: 26616471
Nat Biotechnol. 2015 Jan;33(1):97-101
pubmed: 25503382
Adv Mater. 2018 May;30(22):e1706245
pubmed: 29577477
RSC Adv. 2018 Jan 3;8(2):904-913
pubmed: 35538965
Lab Chip. 2018 Jun 12;18(12):1690-1703
pubmed: 29780982
J Exp Clin Cancer Res. 2016 Oct 26;35(1):168
pubmed: 27782834
J Cell Biochem. 2019 Jun;120(6):10652-10661
pubmed: 30644609
Mol Immunol. 2018 Jun;98:13-18
pubmed: 29525074
Adv Mater. 2017 Feb;29(7):
pubmed: 28009461
Clin Cancer Res. 2020 Jul 1;26(13):3384-3396
pubmed: 32241816
Sci Rep. 2017 Oct 30;7(1):14322
pubmed: 29085024
J Control Release. 2016 Jun 28;232:51-61
pubmed: 27072025
Sci Rep. 2016 Oct 05;6:34422
pubmed: 27703233
J Neuroimmune Pharmacol. 2020 Sep;15(3):554-563
pubmed: 31823250
Sci Rep. 2016 Oct 06;6:34778
pubmed: 27708384
ACS Omega. 2017 Mar 31;2(3):937-945
pubmed: 28393131
Biomaterials. 2017 Oct;142:1-12
pubmed: 28715655
Adv Exp Med Biol. 2018;1064:45-59
pubmed: 30471025
Oncotarget. 2016 Jun 14;7(24):37081-37091
pubmed: 27213597
ACS Nano. 2016 Mar 22;10(3):3323-33
pubmed: 26938862
Sci Rep. 2019 Aug 19;9(1):12065
pubmed: 31427630
J Neurooncol. 2017 Jun;133(2):223-235
pubmed: 28434112
Acta Biomater. 2017 Jul 15;57:274-284
pubmed: 28483695
Int J Nanomedicine. 2020 Mar 19;15:1915-1928
pubmed: 32256068
J Control Release. 2015 Jun 10;207:18-30
pubmed: 25836593
ACS Cent Sci. 2020 Mar 25;6(3):382-389
pubmed: 32232138
Cell Chem Biol. 2018 Aug 16;25(8):931-940
pubmed: 29909993
Int J Nanomedicine. 2016 Nov 02;11:5729-5742
pubmed: 27843314
Theranostics. 2018 Jan 5;8(4):1131-1145
pubmed: 29464004
ACS Nano. 2019 Feb 26;13(2):1272-1283
pubmed: 30673266
J Control Release. 2016 Oct 28;240:527-540
pubmed: 27422609
Small. 2019 Apr;15(17):e1900558
pubmed: 30932344
Drug Deliv Transl Res. 2019 Feb;9(1):249-259
pubmed: 30430452
Mol Ther. 2018 Sep 5;26(9):2107-2118
pubmed: 30017878
Nanomedicine (Lond). 2016 Jul;11(14):1759-67
pubmed: 27389189
J Control Release. 2015 Dec 28;220(Pt B):738-50
pubmed: 26374945
Nanoscale. 2017 Oct 5;9(38):14581-14591
pubmed: 28932838
Nanoscale. 2019 Mar 21;11(12):5377-5394
pubmed: 30849160
Nanoscale. 2016 Apr 7;8(13):6981-5
pubmed: 26975904
Trends Immunol. 2007 Mar;28(3):138-45
pubmed: 17276138
J Immunol Res. 2019 Nov 25;2019:9631515
pubmed: 31886313
Small. 2010 Jan;6(1):12-21
pubmed: 19844908
J Nanobiotechnology. 2019 Jan 22;17(1):14
pubmed: 30670029
Nanomedicine (Lond). 2017 Aug;12(16):2007-2019
pubmed: 28745122
Nat Protoc. 2020 Mar;15(3):773-798
pubmed: 31932772
Biotechnol Adv. 2020 Sep - Oct;42:107339
pubmed: 30639928
J Infect Dis. 2017 Jun 1;215(11):1734-1741
pubmed: 27799353
Nanomedicine. 2015 Apr;11(3):645-55
pubmed: 25596340
J Extracell Vesicles. 2015 Apr 20;4:26316
pubmed: 25899407
Cytotherapy. 2015 Mar;17(3):310-9
pubmed: 25457277
ACS Nano. 2015 Jul 28;9(7):6861-71
pubmed: 26171764
Biosci Rep. 2017 Jun 21;37(3):
pubmed: 28536311
Biomaterials. 2018 Apr;160:124-137
pubmed: 29407341
Adv Healthc Mater. 2018 Feb;7(3):
pubmed: 29193876
Cytotherapy. 2017 Jun;19(6):721-734
pubmed: 28434806
Biomaterials. 2014 Aug;35(25):7172-9
pubmed: 24844163
Adv Sci (Weinh). 2020 Feb 05;7(7):1903301
pubmed: 32274314
Immunol Cell Biol. 2016 Aug;94(7):662-72
pubmed: 26924643
ACS Biomater Sci Eng. 2015;1(4):201-217
pubmed: 25984572
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S166-S179
pubmed: 30092165
J Leukoc Biol. 2009 Nov;86(5):1105-9
pubmed: 19605698
Nanoscale. 2016 Jul 7;8(25):12544-52
pubmed: 26818212
Sci Rep. 2016 Feb 25;6:21933
pubmed: 26911358
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Aug 1;1122-1123:83-89
pubmed: 31173996
Curr Drug Targets. 2015;16(13):1540-7
pubmed: 25382209
Cell Chem Biol. 2018 Jun 21;25(6):648-658
pubmed: 29628434
AAPS J. 2013 Jan;15(1):85-94
pubmed: 23054976
Mol Immunol. 2019 Jul;111:106-117
pubmed: 31051312
Cancer Immunol Res. 2019 Jul;7(7):1188-1201
pubmed: 31113806
Biomater Sci. 2018 May 29;6(6):1379-1389
pubmed: 29652059
Mol Ther. 2017 Dec 6;25(12):2607-2619
pubmed: 28919377
Angew Chem Int Ed Engl. 2020 Mar 2;59(10):4068-4074
pubmed: 31854064
Biomaterials. 2018 Apr;162:71-81
pubmed: 29438882
Nat Biotechnol. 2018 Feb;36(2):160-169
pubmed: 29334370
Small. 2016 Oct;12(37):5108-5119
pubmed: 27560388
Lasers Med Sci. 2018 Nov;33(8):1747-1755
pubmed: 29802587
Angew Chem Int Ed Engl. 2020 Jan 27;59(5):2018-2022
pubmed: 31746532
Int J Nanomedicine. 2019 Aug 20;14:6707-6719
pubmed: 31692512
J Mater Chem B. 2018 Nov 21;6(43):7033-7041
pubmed: 32254586
Curr Biol. 2017 Jul 24;27(14):2065-2077.e6
pubmed: 28669759
Mol Pharm. 2019 Mar 4;16(3):1397-1405
pubmed: 30753778
Cell Immunol. 2018 Dec;334:78-86
pubmed: 30392890
Biomater Sci. 2020 May 21;8(10):2887-2904
pubmed: 32300771
Nat Mater. 2018 Jun;17(6):474-475
pubmed: 29795222
Eur J Pharm Sci. 2017 Jan 1;96:316-322
pubmed: 27720897
Biomaterials. 2017 Aug;135:62-73
pubmed: 28494264
Biomaterials. 2018 Oct;181:35-52
pubmed: 30071380
Nat Rev Neurol. 2015 Jan;11(1):56-64
pubmed: 25385337
Nano Lett. 2018 Mar 14;18(3):1908-1915
pubmed: 29473753
Adv Healthc Mater. 2019 Jun;8(11):e1801271
pubmed: 30997751
Natl Sci Rev. 2019 May;6(3):551-561
pubmed: 34691904
Immunology. 2017 Nov;152(3):462-471
pubmed: 28664991
Theranostics. 2017 Mar 22;7(5):1360-1372
pubmed: 28435471
Cancer Immunol Immunother. 2017 Sep;66(9):1229-1241
pubmed: 28501941
Mol Pharm. 2018 Sep 4;15(9):3625-3633
pubmed: 29771531
EMBO J. 2012 Mar 7;31(5):1062-79
pubmed: 22252128
Nat Commun. 2018 Nov 14;9(1):4777
pubmed: 30429468
Adv Sci (Weinh). 2019 Jun 11;6(15):1900251
pubmed: 31406665
Cancer Res. 2018 Sep 15;78(18):5287-5299
pubmed: 30042153
ACS Appl Mater Interfaces. 2019 Jul 3;11(26):23018-23025
pubmed: 31252477
Int J Nanomedicine. 2019 Jan 11;14:531-541
pubmed: 30666112
Mol Pharm. 2019 Jan 7;16(1):24-40
pubmed: 30513203
Acta Biomater. 2019 Mar 1;86:1-14
pubmed: 30597259
J Pharm Sci. 2017 Sep;106(9):2265-2269
pubmed: 28283433
Adv Healthc Mater. 2019 Aug;8(15):e1900386
pubmed: 31168947
Adv Mater. 2019 Oct;31(43):e1904495
pubmed: 31497903
Nanoscale. 2020 May 21;12(19):10854-10862
pubmed: 32396590
J Pharmacol Exp Ther. 2019 Sep;370(3):715-724
pubmed: 30610006
Chemistry. 2018 Jun 21;24(35):8717-8726
pubmed: 29543990
ACS Appl Mater Interfaces. 2019 Apr 24;11(16):14576-14587
pubmed: 30900870
J Clin Invest. 2016 Apr 1;126(4):1224-32
pubmed: 27035813
Front Immunol. 2017 Jun 09;8:657
pubmed: 28649247
Biomaterials. 2016 Jan;77:243-54
pubmed: 26606450
Nanoscale. 2015 Oct 28;7(40):16631-46
pubmed: 26204104
J Extracell Vesicles. 2019 Mar 12;8(1):1588538
pubmed: 30891164
Biomaterials. 2017 Feb;118:16-26
pubmed: 27940380
Trends Pharmacol Sci. 2009 Nov;30(11):592-9
pubmed: 19837467
Int J Nanomedicine. 2016 Aug 23;11:4107-24
pubmed: 27601898
Nat Mater. 2016 Sep;15(9):1037-46
pubmed: 27213956
J Cell Biol. 1980 Jul;86(1):21-8
pubmed: 7419575
Int J Pharm. 2018 May 5;542(1-2):253-265
pubmed: 29555438
Angew Chem Int Ed Engl. 2017 Oct 9;56(42):12935-12939
pubmed: 28816386
Biomaterials. 2014 Jan;35(1):269-277
pubmed: 24099710
Oncotarget. 2016 Apr 5;7(14):17579-90
pubmed: 27007051
Adv Mater. 2018 Dec;30(50):e1805557
pubmed: 30368972
Adv Mater. 2014 Jul 9;26(26):4497-503
pubmed: 24737409
Theranostics. 2017 Jan 25;7(3):751-763
pubmed: 28255364
Bioconjug Chem. 2018 Dec 19;29(12):4160-4167
pubmed: 30395444
Clin Med Insights Pathol. 2016 Sep 14;9(Suppl 1):1-8
pubmed: 27660518
Int J Mol Sci. 2017 May 24;18(6):
pubmed: 28538671
Sci Transl Med. 2015 Jun 10;7(291):291ra94
pubmed: 26062846
Nano Lett. 2020 Jan 8;20(1):261-271
pubmed: 31786926
Nat Nanotechnol. 2017 Jul;12(7):692-700
pubmed: 28650441
Acta Biomater. 2019 Aug;94:482-494
pubmed: 31129363
Small. 2017 Oct;13(40):
pubmed: 28861943
Nano Lett. 2017 Nov 8;17(11):7045-7054
pubmed: 28994285
Drug Deliv Transl Res. 2018 Aug;8(4):868-882
pubmed: 29058205
Nanomedicine (Lond). 2016;11(5):479-94
pubmed: 26892440
Cancer Immunol Immunother. 2001 Nov;50(9):477-82
pubmed: 11761442
J Drug Target. 2019 Feb;27(2):145-163
pubmed: 29741964
Theranostics. 2017 Jul 22;7(12):3034-3052
pubmed: 28839462
Nat Med. 2010 Sep;16(9):1035-41
pubmed: 20711198
Microb Pathog. 2017 Oct;111:132-138
pubmed: 28843722
Nanoscale. 2016 Jul 7;8(25):12510-9
pubmed: 26750573
ACS Appl Mater Interfaces. 2016 Apr 20;8(15):9610-8
pubmed: 27039688
Drug Deliv. 2019 Dec;26(1):935-943
pubmed: 31530198
J Control Release. 2020 May 10;321:589-601
pubmed: 32114091
Expert Opin Drug Deliv. 2019 Mar;16(3):251-269
pubmed: 30742557
Colloids Surf B Biointerfaces. 2020 Apr;188:110755
pubmed: 31887646
Colloids Surf B Biointerfaces. 2019 Oct 1;182:110353
pubmed: 31336281
Nat Biotechnol. 2020 Aug;38(8):947-953
pubmed: 32361713
J Nanosci Nanotechnol. 2018 Jan 1;18(1):471-485
pubmed: 29768873
J Appl Toxicol. 2010 Apr;30(3):212-7
pubmed: 19902477
ACS Chem Biol. 2018 Aug 17;13(8):2339-2346
pubmed: 29856604
Cell Mol Immunol. 2020 Nov;17(11):1212-1214
pubmed: 32094506
Nat Biotechnol. 2018 Sep;36(8):707-716
pubmed: 29985479
Small. 2019 Oct;15(42):e1902636
pubmed: 31468667
J Drug Target. 2018 Jun - Jul;26(5-6):458-465
pubmed: 29251524
Mol Ther Nucleic Acids. 2018 Dec 7;13:450-463
pubmed: 30388619
Adv Mater. 2018 Nov;30(45):e1802233
pubmed: 30252965
J Control Release. 2017 May 10;253:97-109
pubmed: 28322976
Cancer Lett. 2020 Aug 28;486:18-28
pubmed: 32439419
Nano Lett. 2020 May 13;20(5):4051-4058
pubmed: 32352801
Theranostics. 2019 Feb 28;9(6):1714-1727
pubmed: 31037133
Acc Chem Res. 2019 May 21;52(5):1255-1264
pubmed: 30977635
J Control Release. 2019 Jan 28;294:327-336
pubmed: 30586597
Trends Immunol. 2012 Mar;33(3):119-26
pubmed: 22277903
Cancer Immunol Res. 2018 Jul;6(7):812-824
pubmed: 29720380
ACS Appl Mater Interfaces. 2018 Sep 19;10(37):31124-31135
pubmed: 30141614
Nano Lett. 2018 Aug 8;18(8):4762-4770
pubmed: 30028623
Cell. 2017 Feb 9;168(4):724-740
pubmed: 28187291
Curr Opin Biotechnol. 2019 Aug;58:108-116
pubmed: 30933864
Nanomedicine (Lond). 2015 Jul;10(12):1923-40
pubmed: 26139126
PLoS One. 2015 Sep 29;10(9):e0139043
pubmed: 26418962
Nanomedicine. 2018 Jan;14(1):195-204
pubmed: 28982587
Biomater Sci. 2020 Jan 1;8(1):333-341
pubmed: 31714542
J Immunol. 2018 Aug 15;201(4):1194-1210
pubmed: 29987163
Biomatter. 2012 Oct-Dec;2(4):296-312
pubmed: 23507894
J Immunother. 2020 Apr;43(3):79-88
pubmed: 31834208
Bull Cancer. 2019 Nov;106(11):946-958
pubmed: 31711572
J Environ Pathol Toxicol Oncol. 2017;36(3):229-235
pubmed: 29283336
ACS Nano. 2013 Sep 24;7(9):7698-710
pubmed: 24004438
Mol Pharm. 2017 May 1;14(5):1760-1770
pubmed: 28296410
Small. 2018 Oct;14(42):e1801674
pubmed: 30144279
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3793-3803
pubmed: 31556314
Nanomedicine (Lond). 2020 Mar;15(6):625-641
pubmed: 32098564
Mol Cancer. 2011 Sep 22;10:117
pubmed: 21939504
Nanomedicine. 2016 Apr;12(3):655-664
pubmed: 26586551
Adv Mater. 2017 Apr;29(16):
pubmed: 28199033
ACS Appl Mater Interfaces. 2020 Mar 4;12(9):10130-10141
pubmed: 32041404
Front Immunol. 2018 Oct 01;9:2265
pubmed: 30327656
RSC Adv. 2019 Oct 17;9(57):33378-33387
pubmed: 35529151
Chemphyschem. 2018 May 22;19(10):1205-1214
pubmed: 29327816
Biomaterials. 2013 Oct;34(31):7776-89
pubmed: 23866976
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Nov;9(6):
pubmed: 28296287
J Nanobiotechnology. 2019 Aug 6;17(1):87
pubmed: 31387604
Immunol Res. 2018 Jun;66(3):313-322
pubmed: 29804198
Nano Lett. 2018 Oct 10;18(10):6164-6174
pubmed: 30207473
Macromol Biosci. 2017 Jan;17(1):
pubmed: 27925398
Int J Nanomedicine. 2017 Mar 17;12:2129-2142
pubmed: 28360520
Adv Mater. 2019 May;31(19):e1901179
pubmed: 30924234
Angew Chem Int Ed Engl. 2020 Feb 24;59(9):3732-3738
pubmed: 31834981
Adv Mater. 2016 Sep;28(36):7929-7935
pubmed: 27376951
Adv Healthc Mater. 2019 Jan;8(2):e1801188
pubmed: 30549244
Adv Healthc Mater. 2015 Aug 5;4(11):1645-52
pubmed: 25960053
Adv Mater. 2018 Feb;30(7):
pubmed: 29315824
J Biomed Mater Res A. 2019 Jun;107(6):1213-1224
pubmed: 30672109
Trends Biotechnol. 2014 Sep;32(9):456-65
pubmed: 24998519
Biomaterials. 2019 Jan;190-191:38-50
pubmed: 30391801
PLoS One. 2018 Jul 5;13(7):e0199414
pubmed: 29975720
Front Immunol. 2019 Aug 30;10:2073
pubmed: 31543880
Biomaterials. 2017 Sep;140:79-87
pubmed: 28633046
Theranostics. 2019 May 4;9(10):2910-2923
pubmed: 31244932
Immunopharmacol Immunotoxicol. 2018 Oct;40(5):375-386
pubmed: 30265161
Clin Infect Dis. 2016 Dec 15;63(12):e202-e264
pubmed: 27941151
Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8463-8470
pubmed: 30962374
Adv Healthc Mater. 2016 May;5(9):1088-93
pubmed: 26989887
J Vis Exp. 2018 Mar 2;(133):
pubmed: 29553513
Adv Mater. 2018 Nov;30(46):e1804023
pubmed: 30285289
Nat Nanotechnol. 2013 Jan;8(1):61-8
pubmed: 23241654
J Biomed Mater Res A. 2017 Feb;105(2):521-530
pubmed: 27718539
Biomaterials. 2015 Dec;71:71-83
pubmed: 26318818
Colloids Surf B Biointerfaces. 2018 Nov 1;171:391-397
pubmed: 30064087
Nano Lett. 2019 Jan 9;19(1):124-134
pubmed: 30521345
Nitric Oxide. 2008 Sep;19(2):205-16
pubmed: 18503779
Biol Pharm Bull. 2018;41(6):835-842
pubmed: 29863072
Drug Discov Today. 2018 Jun;23(6):1175-1182
pubmed: 29501911
Eur J Pharm Sci. 2018 May 4;121:34-46
pubmed: 29733979
Theranostics. 2017 Aug 17;7(14):3504-3516
pubmed: 28912891
J Control Release. 2017 Dec 28;268:128-146
pubmed: 29051064
Nat Chem Biol. 2018 Feb 14;14(3):204-205
pubmed: 29443984
ACS Nano. 2011 Jun 28;5(6):4434-47
pubmed: 21563770
Nanoscale. 2016 Feb 14;8(6):3548-54
pubmed: 26804725
Mol Ther. 2017 Jul 5;25(7):1665-1675
pubmed: 28284981
ACS Nano. 2017 Feb 28;11(2):1397-1411
pubmed: 28075552
J Control Release. 2016 Feb 28;224:208-216
pubmed: 26778696
Biomaterials. 2010 Oct;31(30):7606-19
pubmed: 20656344
Biomaterials. 2014 Jul;35(20):5393-5406
pubmed: 24720879
Chem Commun (Camb). 2015 Dec 21;51(98):17428-30
pubmed: 26468496
Nature. 2017 May 24;545(7655):423-431
pubmed: 28541315
J Exp Med. 2005 Dec 19;202(12):1691-701
pubmed: 16365148
J Biomed Nanotechnol. 2019 May 1;15(5):993-1004
pubmed: 30890230
Biomaterials. 2015 Nov;68:9-20
pubmed: 26253804
Am J Adv Drug Deliv. 2018;6(1):21-32
pubmed: 30197907
J Neuroimmune Pharmacol. 2020 Sep;15(3):487-500
pubmed: 31722094
Small. 2017 Mar;13(10):
pubmed: 28026115
Drug Deliv. 2020 Dec;27(1):1-14
pubmed: 31818156
Sci Transl Med. 2018 Jan 17;10(424):
pubmed: 29343626
Front Immunol. 2015 Nov 30;6:605
pubmed: 26648934
Am J Transl Res. 2016 Sep 15;8(9):3700-3709
pubmed: 27725852
ACS Appl Mater Interfaces. 2016 Feb;8(7):4407-15
pubmed: 26824329
Cancer Res. 2018 Feb 1;78(3):798-808
pubmed: 29217761
Theranostics. 2019 Sep 21;9(23):6936-6948
pubmed: 31660078
Biochim Biophys Acta. 2004 Oct 11;1665(1-2):134-41
pubmed: 15471579
Mamm Genome. 2018 Dec;29(11-12):739-756
pubmed: 29987406
Biomaterials. 2016 Jan;74:144-54
pubmed: 26454052
Cells. 2020 Apr 01;9(4):
pubmed: 32244824
Chem Sci. 2018 Mar 16;9(15):3729-3741
pubmed: 29780505
Front Cell Neurosci. 2019 Feb 22;13:41
pubmed: 30853898
Front Oncol. 2020 Jan 21;9:1560
pubmed: 32039028
Chem Commun (Camb). 2018 Oct 14;54(80):11356-11359
pubmed: 30246205
PLoS One. 2014 Sep 17;9(9):e106867
pubmed: 25229627
ACS Appl Mater Interfaces. 2014;6(21):18435-9
pubmed: 25343426
Cancer Biol Med. 2019 Nov;16(4):756-770
pubmed: 31908893
Int J Nanomedicine. 2018 Nov 29;13:8095-8104
pubmed: 30555228
Bioconjug Chem. 2019 Mar 20;30(3):552-560
pubmed: 30779553
J Control Release. 2015 Apr 28;204:11-9
pubmed: 25646783
Adv Mater. 2018 Jun;30(23):e1706780
pubmed: 29682803
Biomater Sci. 2019 Apr 23;7(5):2037-2049
pubmed: 30843911
Drug Deliv. 2018 Nov;25(1):1922-1931
pubmed: 30465444
Nat Cell Biol. 2018 Mar;20(3):307-319
pubmed: 29434374
J Clin Invest. 2017 Jun 1;127(6):2176-2191
pubmed: 28436934
J Tissue Eng Regen Med. 2018 Apr;12(4):e1889-e1898
pubmed: 29193878
Sci Rep. 2015 Dec 03;5:17622
pubmed: 26631690
Anal Chem. 2019 Feb 5;91(3):2425-2430
pubmed: 30620179
Glia. 2001 Nov;36(2):180-90
pubmed: 11596126
Small. 2019 Feb;15(5):e1804191
pubmed: 30549431
Int J Nanomedicine. 2019 Apr 08;14:2465-2483
pubmed: 31040669
Clin Cancer Res. 2007 Mar 15;13(6):1857-67
pubmed: 17363542
Theranostics. 2020 Jan 1;10(3):1281-1295
pubmed: 31938065
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):63-72
pubmed: 27129442
Korean J Parasitol. 2020 Apr;58(2):185-189
pubmed: 32418388
Biomaterials. 2020 Aug;250:119963
pubmed: 32334199
Nat Immunol. 2013 Aug;14(8):793-803
pubmed: 23832071
Small. 2019 May;15(22):e1900903
pubmed: 31026116
Nanomedicine (Lond). 2018 Jan;13(2):157-178
pubmed: 29173008
Biomed Res Int. 2020 Apr 14;2020:5869235
pubmed: 32352001
Acta Biomater. 2020 Mar 1;104:158-166
pubmed: 31954188
Langmuir. 2016 Apr 19;32(15):3637-44
pubmed: 27023433
Clin Transl Oncol. 2019 May;21(5):636-645
pubmed: 30368725
Curr Opin Pharmacol. 2017 Aug;35:12-19
pubmed: 28538141
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11488-11493
pubmed: 29073076
Nanomedicine (Lond). 2018 Aug;13(16):2099-2118
pubmed: 30226404
Theranostics. 2017 Jul 23;7(13):3260-3275
pubmed: 28900508
Biomaterials. 2015 Feb;40:88-97
pubmed: 25465442
Small. 2020 Jan;16(4):e1905185
pubmed: 31880088
Adv Genet. 2017;98:155-175
pubmed: 28942793
Nat Nanotechnol. 2018 Dec;13(12):1182-1190
pubmed: 30177807
Immunol Rev. 2014 Jan;257(1):191-209
pubmed: 24329798
Adv Sci (Weinh). 2021 Mar 01;8(8):2002499
pubmed: 33898169
ACS Nano. 2015 Dec 22;9(12):11800-11
pubmed: 26516654
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7
pubmed: 22451913
Int J Nanomedicine. 2017 Apr 04;12:2759-2767
pubmed: 28435256
Clin Immunol. 2015 Sep;160(1):46-58
pubmed: 25842185
Adv Mater. 2018 May 7;:e1705328
pubmed: 29736981
Mol Cancer. 2020 Aug 6;19(1):120
pubmed: 32762681
Lasers Med Sci. 2015 May;30(4):1357-65
pubmed: 25794592
Sci Rep. 2017 Dec 6;7(1):17095
pubmed: 29213052
Expert Opin Drug Deliv. 2017 Mar;14(3):285-289
pubmed: 27791407
Biomaterials. 2019 Jan;189:60-68
pubmed: 30388590
Biomed Opt Express. 2015 Dec 18;7(1):185-93
pubmed: 26819827
Nano Lett. 2017 Sep 13;17(9):5546-5554
pubmed: 28758755
Biomaterials. 2016 Mar;82:168-77
pubmed: 26761780
J Biol Eng. 2019 Jan 17;13:5
pubmed: 30675178
ACS Nano. 2019 Feb 26;13(2):1078-1096
pubmed: 30608136
Eur J Immunol. 2013 Dec;43(12):3279-90
pubmed: 23943377
Eur J Pharm Sci. 2017 Jan 1;96:115-128
pubmed: 27496050
PLoS One. 2013 Apr 19;8(4):e61852
pubmed: 23620794
Ther Deliv. 2015 Jan;6(1):41-58
pubmed: 25565440
Theranostics. 2017 Jun 25;7(10):2575-2592
pubmed: 28819448
Adv Mater. 2019 Aug;31(34):e1803322
pubmed: 30773696
Biomaterials. 2018 Jan;150:137-149
pubmed: 29040874
ACS Appl Mater Interfaces. 2018 Apr 18;10(15):12341-12350
pubmed: 29564886
ACS Omega. 2020 Jan 13;5(3):1572-1580
pubmed: 32010831
Front Immunol. 2016 Oct 06;7:402
pubmed: 27766097
Breast Cancer Res. 2015 Aug 05;17:101
pubmed: 26243145
J Transl Med. 2010 Jan 15;8:4
pubmed: 20078880
ACS Nano. 2017 Nov 28;11(11):10724-10732
pubmed: 28921946
J Control Release. 2017 Aug 10;259:92-104
pubmed: 28189629
Cells. 2020 Feb 01;9(2):
pubmed: 32024193
Blood. 2019 May 16;133(20):2159-2167
pubmed: 30898857
Nano Lett. 2006 Apr;6(4):662-8
pubmed: 16608261
ACS Nano. 2016 Aug 23;10(8):7738-48
pubmed: 27454827
Bioconjug Chem. 2018 Apr 18;29(4):838-851
pubmed: 29509403
Ultrasound Med Biol. 2018 Jul;44(7):1468-1481
pubmed: 29685589
Adv Mater. 2019 Jun;31(23):e1900192
pubmed: 30916367
Acta Pharm Sin B. 2018 Jan;8(1):4-13
pubmed: 29872618

Auteurs

Leila Pourtalebi Jahromi (LP)

Drug Research Program Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Helsinki FI-00014 Finland.
Pharmaceutical Sciences Research Center Shiraz University of Medical Sciences Shiraz 71468-64685 Iran.
Present address: Helmholtz Institute for Pharmaceutical Research Saarland Helmholtz Centre for Infection Research Biogenic Nanotherapeutics Group Campus E8.1 Saarbrücken 66123 Germany.

Mohammad-Ali Shahbazi (MA)

Drug Research Program Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Helsinki FI-00014 Finland.
Zanjan Pharmaceutical Nanotechnology Research Center (ZPNRC) Zanjan University of Medical Sciences Zanjan 45139-56184 Iran.

Aziz Maleki (A)

Zanjan Pharmaceutical Nanotechnology Research Center (ZPNRC) Zanjan University of Medical Sciences Zanjan 45139-56184 Iran.

Amir Azadi (A)

Pharmaceutical Sciences Research Center Shiraz University of Medical Sciences Shiraz 71468-64685 Iran.
Department of Pharmaceutics School of Pharmacy Shiraz University of Medical Sciences Shiraz 71468-64685 Iran.

Hélder A Santos (HA)

Drug Research Program Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Helsinki FI-00014 Finland.
Helsinki Institute of Life Science (HiLIFE) University of Helsinki Helsinki FI-00014 Finland.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH